Johnson & Johnson cleared in baby powder-cancer litigation case in US

By: |
Published: December 22, 2019 6:11:52 PM

The jury carefully considered the decades of independent clinical evidence, which show Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer.

India is a major market for J&J globally, and its share in the country’s Rs 4,000-crore baby care market is nearly three-fourths.

The baby powder of Johnson & Johnson is not responsible for a Missouri woman’s cancer, a jury in the US has decided in the company’s latest win in a litigation case over its famous product.

The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson, finding Johnson’s baby powder was not the cause of the Vickie Forrest’s disease.

“This is the fourth consecutive verdict in favour of Johnson & Johnson in these cases and the eighth defense verdict this year,” a Johnson & Johnson company spokesperson said in a statement.

The jury carefully considered the decades of independent clinical evidence, which show Johnson’s Baby Powder is safe, does not contain asbestos, and does not cause cancer, it added.

“We know that anyone suffering from cancer is searching for answers, which is why the science and facts on this topic are so important,” the statement said.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1Glenmark Pharmaceutical Inc recalls ranitidine tablets in US
2Reliance-BP petrol pumps to dent PSU market share: Morgan Stanley
3DoT seeks Rs 1.72 lakh cr from GAIL in telecom dues